He served in US Naval Reserves as a combat veteran with over 30 years of experience in areas such as electronic warfare and remote sensing.
Sam Zaidspiner, COO, has successfully launched dozens of products and medical devices. In the past decade, he developed, launched, and scaled all operations for a class 2 medical device that has sold over 3,000,000 units. Bruce Matichuck, CTO, creates AI- based health information platforms including the use of wearable sensors.
Dr. Aaron U. Levy, is a strategic M&A BizDev and Turnaround CEO; he led startup to $1B in MCap NASDAQ Publicly Traded firms and served as CEO, economic development, Native American Tribe with over $1B in operation. An inventor, published author and commercial expert with global operations and manufacturing experience: Biotech, NGS, AI, Clinical, Healthcare, Fiber Optics and YPO.
Mark Cullivan, CFO, has 25 years of management experience in both public and private corporations. He was the CFO of a AMEX listed company. Previously he’s held positions in finance, business development, and marketing. He is an adjunct instructor in the Knauss School of Business at the University of San Diego.
Jared Jones, PhD, Chief Research Officer, was previously Research Director at UnitedHealth Group and led foundational research into innovative diabetes treatments.
Dr. Kevin Kapov was co-investigator on diabetes-related clinical trials and implemented a large-scale CGM treatment program.
Dr. Geraldine Cunniffe-Conlon, MD, MSc and MBA, an ophthalmic surgeon and KOL internationally experienced with R&D and Data Science for Medical and Digital Health technologies.

manage their health. Of this 133 million market size, the two leading competitors have claimed 4 million units annually, based on 2022 reports, however Medicare/Medicaid reimbursement for CGM devices has expanded in the past 12 months. Our projections first 3 years (in units) is 50,000, 160,000, and 320,000 units. We will target the part of the market segment that prefers a non-invasive sensor over an invasive sensor.